Biotin Anti-Collagen IV antibody
3
(1 Review)
|
(10 Publications)
Rabbit Polyclonal COL4A1 antibody - conjugated to Biotin. Suitable for IP, ELISA, WB, IHC-P and reacts with Human, Cow samples. Cited in 10 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human COL4A1.
View Alternative Names
Collagen alpha-1(IV) chain, COL4A1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Biotin Anti-Collagen IV antibody (AB6581)
Immunohistochemical analysis of formalin-fixed paraffin-embedded human tissue sections, labelling Collagen IV with ab6581 at a concentration of 10 μg/mL for 1 hour at room temperature. The left panel is human kidney sections with the right panel being human liver sections. Antigen retrival was performed with 0.01 M sodium citrate buffer at pH 6.0 at 99°C for 20 mins. The secondary used was a rabbit peroxidase secondary antibody at a 1/10,000 dilution incubated for 45 mins at room temperature. Counterstaining against nuclear DNA was hematoxylin.
Reactivity data
Product details
At least 11 genetically distinct gene products are collectively referred to as 'collagen types' or other proteins and proteoglycans of the extracellular matrix. In humans, collagens are composed of about 20 unique protein chains which under go various types of post-translational modifications and are ultimately assembled into a triple helix. This results in great diversity between collagen types. Collagens are highly conserved throughout evolution and are characterized by an uninterrupted "Glycine-X-Y" triplet repeat that is a necessary part of the triple helical structure. For these reasons it is often extremely difficult to generate antibodies with specificities to collagens. The development of type specific antibodies is dependent on NON-DENATURED three-dimensional epitopes. This preparation results in a native conformation of the protein.
These antibodies are well suited to detect extracellular matrix proteins in normal as well as disease state tissues. Disruption of tissue organization is the hallmark of neoplasia. Malignant lesions can be distinguished from benign by examining the breakdown of basement membranes and loss of 3-dimensional architecture. Malignant cells are presumed to use matrix metalloproteases to degrade barriers created by the extracellular matrix which then allows metastasis to occur. Collagenases, stomelysins and gelatinases can collectively degrade all of the various components of the extracellular matrix, including fibrillar and non-fibrillar collagens and basement membrane glycoproteins.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The highly organized network of collagen type IV plays a supreme role in maintaining the integrity and functionality of the basement membrane. It exists predominantly as part of a supramolecular complex associating with laminin nidogen and perlecan forming a multifunctional platform. This platform facilitates cellular signaling tissue elasticity and filtration functions. The basement membrane's selective permeability heavily relies on this network structure to regulate the exchange of molecules between tissues like blood vessels and epithelial sheets.
Pathways
Collagen IV contributes to several critical functions within the extracellular matrix organization and cell-matrix adhesion pathways. Specifically it interacts intimately with integrins and matrix metalloproteinases (MMPs) playing roles in angiogenesis and tissue repair. Additionally its interactions with other collagens and integrins within these pathways enhance cellular responses to mechanical stress and contribute to structural resilience in tissues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Journal of neuroinflammation 21:72 PubMed38521959
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 20:179 PubMed37516868
2023
Applications
Unspecified application
Species
Unspecified reactive species
Fluids and barriers of the CNS 20:24 PubMed37013659
2023
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 9:324 PubMed30463594
2018
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 9:252 PubMed30257706
2018
Applications
Unspecified application
Species
Unspecified reactive species
ACS applied materials & interfaces 8:21848-60 PubMed27136321
2016
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 11:3734-40 PubMed25592406
2015
Applications
Unspecified application
Species
Unspecified reactive species
Macromolecular bioscience 13:1135-49 PubMed23832790
2013
Applications
IHC
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 189:2181-90 PubMed22844119
2012
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of neuroscience : the official journal of the Society for Neuroscience 32:9805-16 PubMed22815495
2012
Applications
IHC
Species
Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com